tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
Holding KZR?
Track your performance easily

Kezar Life Sciences (KZR) Financial Statements

468 Followers

Kezar Life Sciences Financial Overview

Kezar Life Sciences's market cap is currently ―. The company's EPS TTM is $-13.152; its P/E ratio is -0.57; Kezar Life Sciences is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue----$ 7.00M
Gross Profit----$ 7.00M
EBIT$ -19.91M$ -21.15M$ -21.26M$ -31.86M$ -22.71M
EBITDA$ -19.59M$ -19.31M$ -21.00M$ -31.58M$ -22.43M
Net Income Common Stockholders$ -20.31M$ -21.55M$ -21.66M$ -32.26M$ -23.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 148.39M$ 164.18M$ 179.80M$ 201.37M$ 218.21M
Total Assets$ 164.09M$ 179.92M$ 199.13M$ 221.24M$ 249.33M
Total Debt$ 16.91M$ 17.61M$ 18.29M$ 18.93M$ 19.55M
Net Debt$ -131.48M$ -146.57M$ -161.51M$ -182.44M$ -198.65M
Total Liabilities$ 30.04M$ 29.24M$ 30.01M$ 33.66M$ 33.33M
Stockholders Equity$ 134.05M$ 150.69M$ 169.14M$ 187.57M$ 215.99M
Cash Flow-
Free Cash Flow$ -17.51M$ -17.03M$ -22.86M$ -18.98M$ -20.34M
Operating Cash Flow$ -17.49M$ -17.03M$ -22.86M$ -18.98M$ -20.20M
Investing Cash Flow$ 24.06M$ 12.22M$ 20.41M$ 27.88M$ 18.57M
Financing Cash Flow-$ 56.00K-$ 59.00K$ 43.00K
Currency in USD

Kezar Life Sciences Earnings and Revenue History

Kezar Life Sciences Debt to Assets

Kezar Life Sciences Cash Flow

Kezar Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis